Relationship between Volatile Anesthetics and Tumor Progression: Unveiling the Mystery
暂无分享,去创建一个
[1] Seung-Hyun Lee,et al. Effect of Equipotent Doses of Propofol versus Sevoflurane Anesthesia on Regulatory T Cells after Breast Cancer Surgery , 2018, Anesthesiology.
[2] H. Kim,et al. Impact of anesthetic agents on overall and recurrence-free survival in patients undergoing esophageal cancer surgery: A retrospective observational study , 2017, Scientific Reports.
[3] J. H. Lee,et al. The Effects of Perioperative Anesthesia and Analgesia on Immune Function in Patients Undergoing Breast Cancer Resection: A Prospective Randomized Study , 2017, International journal of medical sciences.
[4] Koichi Yuki,et al. The effect of different anesthetics on tumor cytotoxicity by natural killer cells. , 2017, Toxicology letters.
[5] Bin Zhang,et al. Sevoflurane attenuates platelets activation of patients undergoing lung cancer surgery and suppresses platelets-induced invasion of lung cancer cells. , 2016, Journal of clinical anesthesia.
[6] Q. Lian,et al. Volatile anaesthetics enhance the metastasis related cellular signalling including CXCR2 of ovarian cancer cells , 2016, Oncotarget.
[7] Robert E. Brown,et al. The effects of anesthesia on the morphoproteomic expression of head and neck squamous cell carcinoma: a pilot study. , 2015, Translational research : the journal of laboratory and clinical medicine.
[8] Dong Yeon Kim,et al. Effect of Propofol and Desflurane on Immune Cell Populations in Breast Cancer Patients: A Randomized Trial , 2015, Journal of Korean medical science.
[9] Hailin Zhao,et al. The potential role of HIF on tumour progression and dissemination , 2015, International journal of cancer.
[10] Bin Zhang,et al. Sevoflurane suppresses hypoxia-induced growth and metastasis of lung cancer cells via inhibiting hypoxia-inducible factor-1α , 2015, Journal of Anesthesia.
[11] Q. Shi,et al. Sevoflurane promotes the expansion of glioma stem cells through activation of hypoxia-inducible factors in vitro. , 2015, British journal of anaesthesia.
[12] J. Liu,et al. Impact of isoflurane on malignant capability of ovarian cancer in vitro. , 2015, British journal of anaesthesia.
[13] R. Berkowitz,et al. Anesthetic Selection and Disease-Free Survival Following Optimal Primary Cytoreductive Surgery for Stage III Epithelial Ovarian Cancer , 2015, Annals of Surgical Oncology.
[14] R. Brown,et al. Prostate cancer cell malignancy via modulation of HIF-1α pathway with isoflurane and propofol alone and in combination , 2014, British Journal of Cancer.
[15] P. Doran,et al. Effects of sevoflurane on breast cancer cell function in vitro. , 2013, Anticancer research.
[16] D. Ma,et al. Isoflurane, a Commonly Used Volatile Anesthetic, Enhances Renal Cancer Growth and Malignant Potential via the Hypoxia-inducible Factor Cellular Signaling Pathway In Vitro , 2013, Anesthesiology.
[17] B. Beck-Schimmer,et al. Volatile Anesthetics Reduce Invasion of Colorectal Cancer Cells through Down-regulation of Matrix Metalloproteinase-9 , 2012, Anesthesiology.
[18] D. Ma,et al. Cancer recurrence after surgery: Direct and indirect effects of anesthetic agents * , 2012, International journal of cancer.
[19] H. Karadaşli,et al. Comparison of effects of low-flow sevoflurane and desflurane anesthesia on neutrophil and T-cell populations. , 2012, Current therapeutic research, clinical and experimental.
[20] A. Miyanohara,et al. Volatile Anesthetics Protect Cancer Cells against Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Apoptosis via Caveolins , 2011, Anesthesiology.
[21] P. Doran,et al. Effect of Anesthetic Technique on Serum Vascular Endothelial Growth Factor C and Transforming Growth Factor &bgr; in Women Undergoing Anesthesia and Surgery for Breast Cancer , 2010, Anesthesiology.
[22] E. Mascha,et al. Anesthetic Technique and the Cytokine and Matrix Metalloproteinase Response to Primary Breast Cancer Surgery , 2010, Regional Anesthesia & Pain Medicine.
[23] J. Meyerhardt,et al. HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers. , 2010, The American journal of pathology.
[24] S. Qiu,et al. Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery , 2009, BMC Cancer.
[25] P. Doran,et al. Effect of anaesthetic technique on oestrogen receptor-negative breast cancer cell function in vitro. , 2009, British journal of anaesthesia.
[26] M. Vieth,et al. HIF-1α determines the metastatic potential of gastric cancer cells , 2009, British Journal of Cancer.
[27] R. Eckenhoff,et al. The Common Inhalational Anesthetic Isoflurane Induces Apoptosis via Activation of Inositol 1,4,5-Trisphosphate Receptors , 2008, Anesthesiology.
[28] B. Plaud,et al. Reactive Oxygen Species Mediate Sevoflurane- and Desflurane-Induced Preconditioning in Isolated Human Right Atria In Vitro , 2007, Anesthesia and analgesia.
[29] G. Melillo,et al. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma. , 2007, Human pathology.
[30] B. Zwissler,et al. Isoflurane Inhalation after Induction of Endotoxemia in Rats Attenuates the Systemic Cytokine Response , 2007, European Surgical Research.
[31] Stefano Papa,et al. NK Cells and Cancer1 , 2007, The Journal of Immunology.
[32] T. Kietzmann,et al. Reactive Oxygen Species Activate the HIF-1&agr; Promoter Via a Functional NF&kgr;B Site , 2007 .
[33] P. Pagel,et al. Extracellular Signal-Regulated Kinases Trigger Isoflurane Preconditioning Concomitant with Upregulation of Hypoxia-Inducible Factor-1&agr; and Vascular Endothelial Growth Factor Expression in Rats , 2006, Anesthesia and analgesia.
[34] Manuela Milani,et al. Hypoxia-Inducible Factor-1α Expression Predicts a Poor Response to Primary Chemoendocrine Therapy and Disease-Free Survival in Primary Human Breast Cancer , 2006, Clinical Cancer Research.
[35] J. Maranchie,et al. Nox4 is critical for hypoxia-inducible factor 2-alpha transcriptional activity in von Hippel-Lindau-deficient renal cell carcinoma. , 2005, Cancer research.
[36] L. Glavaš-Obrovac,et al. Effects of inhalation anesthetics halothane, sevoflurane, and isoflurane on human cell lines. , 2005, Life sciences.
[37] S. Ansorge,et al. Effects of different anaesthetic agents on immune cell function in vitro , 2005, European journal of anaesthesiology.
[38] C. Borner,et al. Volatile Anesthetics Induce Caspase-dependent, Mitochondria-mediated Apoptosis in Human T Lymphocytes In Vitro , 2005, Anesthesiology.
[39] Naphtali Abudarham,et al. Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a β-adrenergic antagonist and a prostaglandin synthesis inhibitor , 2005, Brain, Behavior, and Immunity.
[40] K. Shingu,et al. Effect of propofol and isoflurane anaesthesia on the immune response to surgery * , 2004, Anaesthesia.
[41] G. Shakhar,et al. Suppression of Natural Killer Cell Activity and Promotion of Tumor Metastasis by Ketamine, Thiopental, and Halothane, but Not by Propofol: Mediating Mechanisms and Prophylactic Measures , 2003, Anesthesia and analgesia.
[42] M. Miyazaki,et al. Natural killer cell activity and distant metastasis in rectal cancers treated surgically with and without neoadjuvant chemoradiotherapy. , 2003, Journal of the American College of Surgeons.
[43] W. Schlack,et al. Isoflurane Preconditions Myocardium against Infarction via Release of Free Radicals , 2002, Anesthesiology.
[44] J. Wang,et al. General versus regional anaesthesia for cataract surgery: effects on neutrophil apoptosis and the postoperative pro-inflammatory state. , 2000, European journal of anaesthesiology.
[45] A. Matsuki,et al. Expression of genes for proinflammatory cytokines in alveolar macrophages during propofol and isoflurane anesthesia. , 1999, Anesthesia and analgesia.
[46] S. Zahler,et al. Sevoflurane and isoflurane protect the reperfused guinea pig heart by reducing postischemic adhesion of polymorphonuclear neutrophils. , 1999, Anesthesiology.
[47] A. Matsuki,et al. Volatile anesthetics augment expression of proinflammatory cytokines in rat alveolar macrophages during mechanical ventilation. , 1999, Anesthesiology.
[48] S. Zahler,et al. Inhibition of neutrophil activation by volatile anesthetics decreases adhesion to cultured human endothelial cells. , 1999, Anesthesiology.
[49] G. Shakhar,et al. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity , 1999, International journal of cancer.
[50] A. Matsuki,et al. Intraoperative Modulation of Alveolar Macrophage Function during Isoflurane and Propofol Anesthesia , 1998, Anesthesiology.
[51] G. Shakhar,et al. In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. , 1998, Journal of immunology.
[52] K. Koda,et al. Preoperative natural killer cell activity: correlation with distant metastases in curatively research colorectal carcinomas. , 1997, International surgery.
[53] S. Zahler,et al. Halothane, Isoflurane, and Sevoflurane Reduce Postischemic Adhesion of Neutrophils in the Coronary System , 1997, Anesthesiology.
[54] Julie Brittenden,et al. Natural killer cells and cancer , 1996, Cancer.
[55] M. Yokoyama,et al. Suppressive effects of volatile anesthetics on cytokine release in human peripheral blood mononuclear cells. , 1995, International journal of immunopharmacology.
[56] S. Markovic,et al. Anesthesia inhibits interferon-induced natural killer cell cytotoxicity via induction of CD8+ suppressor cells. , 1993, Cellular immunology.
[57] I. Penn. The effect of immunosuppression on pre-existing cancers. , 1993, Transplantation.
[58] I. Penn,et al. Effect of immunosuppression on preexisting cancers. , 1993, Transplantation proceedings.
[59] S. Segal,et al. Anesthetic drugs accelerate the progression of postoperative metastases of mouse tumors. , 1981, The Journal of clinical investigation.
[60] T. Kietzmann,et al. Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site. , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[61] Manuela Milani,et al. Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.
[62] P. Basse,et al. Antitumor activity of NK cells , 2006, Immunologic research.
[63] B. Brown,et al. Evidence for the role of natural immunity in the control of metastatic spread of head and neck cancer , 2004, Cancer Immunology, Immunotherapy.
[64] D. Singal,et al. Halothane and isoflurane enhance melanoma tumour metastasis in mice , 1997, Canadian journal of anaesthesia = Journal canadien d'anesthesie.